MREO
Mereo BioPharma Group PLC ADR
NASDAQ: MREO · HEALTHCARE · BIOTECHNOLOGY
$0.27
-2.89% today
Updated 2026-04-30
Market cap
$44.72M
P/E ratio
—
P/S ratio
89.45x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$0 – $3
Volume
1.6M
Mereo BioPharma Group PLC ADR (MREO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6.70M | $-27.40M | $-32.15M | $-23.14M | $-60.22M | $-38.62M | $-7.07M | $-48.82M | $-21.13M | $-32.83M | $-30.97M |
| Capital expenditures | $215880.00 | $3467.00 | $2.30M | $35536.00 | $27534.00 | $21805.00 | $722055.00 | $13000.00 | $419000.00 | $699000.00 | $20000.00 |
| Depreciation | $11360.00 | $32940.00 | $36076.00 | $37796.00 | $2.07M | $2.18M | $866466.00 | $889000.00 | $1.06M | $1.09M | — |
| Stock-based comp | — | $6.49M | $3.65M | $2.19M | $2.15M | $2.12M | $4.46M | $4.77M | $4.92M | $7.39M | $7.60M |
| Free cash flow | $-6.91M | $-27.40M | $-34.44M | $-23.17M | $-60.25M | $-38.65M | $-7.79M | $-48.83M | $-21.55M | $-33.53M | $-30.99M |
| Investing cash flow | $-190160.00 | $372614.00 | $-3.74M | $251558.00 | $56.77M | $2.04M | $-568197.00 | $1.99M | $-419000.00 | $-699000.00 | — |
| Financing cash flow | $19.14M | $68.36M | $33.74M | $-2.07M | $-7.49M | $47.34M | $104.80M | $200000.00 | $7.97M | $46.15M | — |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |